News

MitoQ, based on a novel technology, targets lipophilic cations that transport and concentrate antioxidants into the mitochondria where they accumulate up to 1000 fold. Patients who meet the

As per the deal, Z-Cube will sponsor a research program to be conducted by Prof. Touitou and her group. Z-Cube will have worldwide exclusive rights to develop and

The order is a part of present pandemic stockpile contract between Sanofi and the US government that allows HHS to purchase vaccines for viruses with pandemic potential. Besides

Dr. McNamee, MD of CSL, has presented the pro-competitive arguments of CSL’s case with the FTC staff, including efficiencies and benefits to consumers resulting out of the acquisition,

The company, which supports governments and health authorities around the world to respond to the emergence of the new A (H1N1) influenza strain, is a manufacturer of both

Dzherelo is now classified under complementary medicines category by MCC of the Department of Health, in South Africa. Moreover, this drug was recently approved in Mongolia. Immunoxel is

Bayer plans to familiarize US growers with the features, benefits, and the varieties of the new technology. The company initially plans to offer two high-yielding Gly Tol cotton

Shionogi’s treatment is said to be effective even after 48 hours from the emergence of symptoms, unlike the “Tamiflu” influenza medication, which must be administered within 48 hours.

HHS is also in talks with other manufacturers to increase capacity. These manufacturers will receive another $150 million to produce pilot lots of vaccine and to pay for